Medicilon and Protheragen Forge Strategic Partnership to Build a Collaborative “Project + Platform” Model

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

On April 6, Medicilon formally signed a strategic cooperation agreement with Protheragen and its affiliated companies. Leveraging a collaborative “Project + Platform” model, the two parties will integrate Protheragen’s strengths in innovative drug incubation and global project sourcing with Medicilon’s one-stop preclinical pharmaceutical R&D service platform, jointly building an efficient, compliant and internationalized drug R&D […]

Search Medicilon

Preclinical CRO

KSNS 2026

Medicilon Events

Nordic PMF 2026

Preclinical CRO

AACR 2026 Special Report: An In-Depth Review of Medicilon’s Three Technical Posters | Bilingual

Contact Medicilon

Name(Required)
Address(Required)